Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.

Hanania NA, Alpan O, Hamilos DL, Condemi JJ, Reyes-Rivera I, Zhu J, Rosen KE, Eisner MD, Wong DA, Busse W.

Ann Intern Med. 2011 May 3;154(9):573-82. doi: 10.7326/0003-4819-154-9-201105030-00002.

PMID:
21536936
[PubMed - indexed for MEDLINE]
2.

Omalizumab: clinical use for the management of asthma.

Thomson NC, Chaudhuri R.

Clin Med Insights Circ Respir Pulm Med. 2012;6:27-40. doi: 10.4137/CCRPM.S7793. Epub 2012 Jun 12.

PMID:
22745565
[PubMed]
Free PMC Article
3.

Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma.

Gevaert P, Calus L, Van Zele T, Blomme K, De Ruyck N, Bauters W, Hellings P, Brusselle G, De Bacquer D, van Cauwenberge P, Bachert C.

J Allergy Clin Immunol. 2013 Jan;131(1):110-6.e1. doi: 10.1016/j.jaci.2012.07.047. Epub 2012 Sep 27.

PMID:
23021878
[PubMed - indexed for MEDLINE]
4.

Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma.

Chipps BE, Figliomeni M, Spector S.

Allergy Asthma Proc. 2012 Sep-Oct;33(5):377-85. doi: 10.2500/aap.2012.33.3599.

PMID:
23026179
[PubMed - indexed for MEDLINE]
5.

Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children.

Busse WW, Morgan WJ, Gergen PJ, Mitchell HE, Gern JE, Liu AH, Gruchalla RS, Kattan M, Teach SJ, Pongracic JA, Chmiel JF, Steinbach SF, Calatroni A, Togias A, Thompson KM, Szefler SJ, Sorkness CA.

N Engl J Med. 2011 Mar 17;364(11):1005-15. doi: 10.1056/NEJMoa1009705.

PMID:
21410369
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal.

Burch J, Griffin S, McKenna C, Walker S, Paton J, Wright K, Woolacott N.

Pharmacoeconomics. 2012 Nov 1;30(11):991-1004. doi: 10.2165/11597160-000000000-00000. Review.

PMID:
22950547
[PubMed - indexed for MEDLINE]
7.

Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study.

Hanania NA, Wenzel S, Rosén K, Hsieh HJ, Mosesova S, Choy DF, Lal P, Arron JR, Harris JM, Busse W.

Am J Respir Crit Care Med. 2013 Apr 15;187(8):804-11. doi: 10.1164/rccm.201208-1414OC.

PMID:
23471469
[PubMed - indexed for MEDLINE]
8.

Longitudinal changes in asthma control with omalizumab: 2-year interim data from the EXCELS Study.

Eisner MD, Zazzali JL, Miller MK, Bradley MS, Schatz M.

J Asthma. 2012 Aug;49(6):642-8. doi: 10.3109/02770903.2012.690477.

PMID:
22793527
[PubMed - indexed for MEDLINE]
9.

Does omalizumab make a difference to the real-life treatment of asthma exacerbations?: Results from a large cohort of patients with severe uncontrolled asthma.

Grimaldi-Bensouda L, Zureik M, Aubier M, Humbert M, Levy J, Benichou J, Molimard M, Abenhaim L; Pharmacoepidemiology of Asthma and Xolair (PAX) Study Group.

Chest. 2013 Feb 1;143(2):398-405.

PMID:
23505637
[PubMed - indexed for MEDLINE]
10.

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.

Humbert M, Beasley R, Ayres J, Slavin R, Hébert J, Bousquet J, Beeh KM, Ramos S, Canonica GW, Hedgecock S, Fox H, Blogg M, Surrey K.

Allergy. 2005 Mar;60(3):309-16.

PMID:
15679715
[PubMed - indexed for MEDLINE]
11.

The oral corticosteroid-sparing effect of omalizumab in children with severe asthma.

Brodlie M, McKean MC, Moss S, Spencer DA.

Arch Dis Child. 2012 Jul;97(7):604-9. doi: 10.1136/archdischild-2011-301570. Epub 2012 Jun 9.

PMID:
22685051
[PubMed - indexed for MEDLINE]
12.

Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX).

Rubin AS, Souza-Machado A, Andradre-Lima M, Ferreira F, Honda A, Matozo TM; QUALITX Study Investigators.

J Asthma. 2012 Apr;49(3):288-93. doi: 10.3109/02770903.2012.660297. Epub 2012 Feb 23.

PMID:
22356355
[PubMed - indexed for MEDLINE]
13.

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.

Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, van As A, Gupta N.

J Allergy Clin Immunol. 2001 Aug;108(2):184-90.

PMID:
11496232
[PubMed - indexed for MEDLINE]
14.

Monitoring free serum IgE in severe asthma patients treated with omalizumab.

Korn S, Haasler I, Fliedner F, Becher G, Strohner P, Staatz A, Taube C, Buhl R.

Respir Med. 2012 Nov;106(11):1494-500. doi: 10.1016/j.rmed.2012.07.010. Epub 2012 Aug 11.

PMID:
22884459
[PubMed - indexed for MEDLINE]
15.

Impact of omalizumab on emergency-department visits, hospitalizations, and corticosteroid use among patients with uncontrolled asthma.

Lafeuille MH, Dean J, Zhang J, Duh MS, Gorsh B, Lefebvre P.

Ann Allergy Asthma Immunol. 2012 Jul;109(1):59-64. doi: 10.1016/j.anai.2012.04.015. Epub 2012 May 12.

PMID:
22727159
[PubMed - indexed for MEDLINE]
16.

Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma.

Lanier B, Bridges T, Kulus M, Taylor AF, Berhane I, Vidaurre CF.

J Allergy Clin Immunol. 2009 Dec;124(6):1210-6. doi: 10.1016/j.jaci.2009.09.021. Epub .

PMID:
19910033
[PubMed - indexed for MEDLINE]
17.

Omalizumab and asthma control in patients with moderate-to-severe allergic asthma: a 6-year pragmatic data review.

Storms W, Bowdish MS, Farrar JR.

Allergy Asthma Proc. 2012 Mar-Apr;33(2):172-7. doi: 10.2500/aap.2012.33.3527.

PMID:
22525394
[PubMed - indexed for MEDLINE]
18.

Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).

Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, Taylor AF, Rohane P.

Pediatrics. 2001 Aug;108(2):E36.

PMID:
11483846
[PubMed - indexed for MEDLINE]
19.

Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years.

Walker S, Burch J, McKenna C, Wright K, Griffin S, Woolacott N.

Health Technol Assess. 2011 May;15 Suppl 1:13-21. doi: 10.3310/hta15suppl1/02. Review.

PMID:
21609649
[PubMed - indexed for MEDLINE]
Free Article
20.

Effects of omalizumab in non-atopic asthma: results from a Spanish multicenter registry.

de Llano LP, Vennera Mdel C, Álvarez FJ, Medina JF, Borderías L, Pellicer C, González H, Gullón JA, Martínez-Moragón E, Sabadell C, Zamarro S, Picado C; Spanish Registry.

J Asthma. 2013 Apr;50(3):296-301. doi: 10.3109/02770903.2012.757780. Epub 2013 Jan 28. Erratum in: J Asthma. 2013 Jun;50(5):537-9.

PMID:
23350994
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk